Early Stage Development - Integrated Programs

Products

Information

Accelerating molecules through to proof-of-concept - Simplify early development and accelerate to Proof-of Concept.Proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We understand the transition to POC needs to be fast and cost-effective.With fully integrated capabilities from first-in-human testing to seamless drug product supply for patient trials, we simplify early development and accelerate molecules through to POC.
All Categories
Analytical Chemistry (Biopharmaceutical Products)Analytical Methods (Biopharmaceutical Products)Other APIs
Main Categories
Biopharmaceutical ProductsInnovative APIs
Distribution Areas
North America (USA, Canada)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
United KingdomUnited States
QUOTIENT SCIENCES LIMITEDQuotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small molecules & peptide drug programs. We cut through silos across a range of drug development capabilities, saving precious time and money in getting drugs to patients. We work with customers in a flexible way by either designing and delivering fully integrated programs at each stage of the development lifecycle, or by providing them support through tailored individual services in Drug Substance Synthesis & Manufacturing, Formula...

Log in

See all the content and easy-to-use features by logging in or registering!